Detalhe da pesquisa
1.
Thrombopoietin receptor agonist for treating bone marrow aplasia following anti-CD19 CAR-T cells-single-center experience.
Ann Hematol
; 101(8): 1769-1776, 2022 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-35731278
2.
Polatuzumab-based regimen or CAR T cell for patients with refractory/relapsed DLBCL-a matched cohort analysis.
Ann Hematol
; 101(4): 755-762, 2022 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-35083525
3.
Haematological patients' perception of home transfusions: Effect of the COVID-19 pandemic.
Vox Sang
; 117(10): 1195-1201, 2022 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-36102110
4.
BNT162b2 COVID-19 vaccine is significantly less effective in patients with hematologic malignancies.
Am J Hematol
; 96(10): 1195-1203, 2021 10 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34185336
5.
Management and Outcome of Venous Thrombosis in Patients with Myeloproliferative Neoplasms: Data from the Israeli MPN Working Group.
Acta Haematol
; 144(4): 438-445, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-33316809
6.
Frontline treatment with the combination obinutuzumab ± chlorambucil for chronic lymphocytic leukemia outside clinical trials: Results of a multinational, multicenter study by ERIC and the Israeli CLL study group.
Am J Hematol
; 95(6): 604-611, 2020 06.
Artigo
Inglês
| MEDLINE | ID: mdl-32096887
7.
Efficacy of front-line ibrutinib versus fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: A retrospective multicenter "Real-World" study.
Am J Hematol
; 98(2): E24-E27, 2023 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36349541
8.
Timing of BNT162b2 vaccine prior to COVID-19 infection, influence disease severity in patients with hematologic malignancies: Results from a cohort study.
Cancer Med
; 12(21): 20503-20510, 2023 11.
Artigo
Inglês
| MEDLINE | ID: mdl-37877352
9.
Lymphoproliferative disease detected by breast cancer screening.
J Med Screen
; 29(4): 255-259, 2022 12.
Artigo
Inglês
| MEDLINE | ID: mdl-35818749
10.
Hereditary thrombotic thrombocytopenic purpura and COVID-19: Impacts of vaccination and infection in this rare disease.
Res Pract Thromb Haemost
; 6(7): e12814, 2022 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-36284639
11.
Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL.
J Hematol Oncol
; 15(1): 116, 2022 08 26.
Artigo
Inglês
| MEDLINE | ID: mdl-36028857
12.
Acquired thrombotic thrombocytopenic purpura: A rare disease associated with BNT162b2 vaccine.
J Thromb Haemost
; 19(9): 2314-2317, 2021 09.
Artigo
Inglês
| MEDLINE | ID: mdl-34105247
13.
Outcome of relapsed/refractory diffuse large B-cell lymphoma patients treated with polatuzumab vedotin-based therapy: real-life experience.
Leuk Lymphoma
; 62(1): 118-124, 2021 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32981410
14.
COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study.
Leukemia
; 35(12): 3444-3454, 2021 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34725454
15.
Bone marrow expression of CCL3 is not correlated with the extent of lytic bone lesions.
Acta Haematol
; 132(2): 129-33, 2014.
Artigo
Inglês
| MEDLINE | ID: mdl-24556596
16.
Prevalence of Paroxysmal Nocturnal Hemoglobinuria Clones in Myeloproliferative Neoplasm Patients: A Cross-Sectional Study.
Clin Lymphoma Myeloma Leuk
; 19(12): 812-814, 2019 12.
Artigo
Inglês
| MEDLINE | ID: mdl-31601527
17.
Treatment and prognosis of stage I follicular lymphoma in the modern era - does PET matter?
Leuk Lymphoma
; 59(5): 1163-1171, 2018 05.
Artigo
Inglês
| MEDLINE | ID: mdl-28901817
18.
Ruxolitinib treatment for myelofibrosis: Efficacy and tolerability in routine practice.
Leuk Res
; 2015 Aug 12.
Artigo
Inglês
| MEDLINE | ID: mdl-26364797
19.
The proliferation arrest of primary tumor cells out-of-niche is associated with widespread downregulation of mitotic and transcriptional genes.
Hematology
; 19(5): 286-92, 2014 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-24074379
20.
Multiple myeloma cells recruit tumor-supportive macrophages through the CXCR4/CXCL12 axis and promote their polarization toward the M2 phenotype.
Oncotarget
; 5(22): 11283-96, 2014 Nov 30.
Artigo
Inglês
| MEDLINE | ID: mdl-25526031